Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Madrigal Pharmaceuticals Inc (NASDAQ:MDGL)

15.75
Delayed Data
As of Aug 18
 +0.13 / +0.83%
Today’s Change
8.54
Today|||52-Week Range
18.24
+5.70%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 3
2016
Quarter 4
2016
Quarter 1
2017
Quarter 2
2017
AssetsCash8.4M19.1M8.2M34.8M
 
 
 
 
 
Short Term Investment Cash32.3M10.8M-10.9M26.6M
 
 
 
 
 
Cash & Short Term Investments39.6M40.5M40.1M67.2M
 
 
 
 
 
 
ReceivablesReceivables0.000.000.000.00--
 
InventoriesInventories0.000.000.000.00--
 
Current AssetsOther Current Assets1.6M708.0K225.0K781.0K
 
 
 
 
 
Current Assets41.2M41.2M40.4M67.9M
 
 
 
 
 
 
Total AssetsIntangible Assets315.1K0.000.000.00
 
 
Other Assets315.1K0.000.000.00
 
 
Total Assets41.5M41.2M40.4M68.1M
 
 
 
 
 
 
LiabilitiesAccounts Payable1.2M762.0K2.8M1.3M
 
 
 
 
 
Accrued Expenses2.8M4.0M3.1M5.2M
 
 
 
 
 
Other Current Liabilities2.8M4.0M3.1M5.2M
 
 
 
 
 
Other Liabilities3.9M4.8M5.9M6.4M
 
 
 
 
 
 
Total LiabilitiesTotal Liabilities3.9M4.8M5.9M6.4M
 
 
 
 
 
 
EquityMinority Interest0.000.000.000.00--
Preferred Stock0.000.000.000.00--
Common Equity37.6M36.4M34.5M61.6M
 
 
 
 
 
Total Shareholder Equity37.6M36.4M34.5M61.6M
 
 
 
 
 
 
Share InformationCommon Shares Outstanding11.6M12.0M12.2M12.5M
 
 
 
 
 
 
Addtl. Info.No data currently available for this section.